(CHMA) - Earnings & Price History

CHMA: - 1.975, $51.15M, -0.13 (-5.95%)

Sector: Healthcare - Industry: Biotechnology

Chiasma, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing oral forms of therapies for patients suffering from orphan diseases. Its product candidate is octreotide capsules or MYCAPSSA, which has completed Phase III clinical trial for the treatment of acromegaly, a condition that results in the bodys production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Newton, Massachusetts.Key Statistics

Past CHMA reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-13AMC-0.371.71.751.71.651.75-2.86%-2.86%46.48K
2016-08-10AMC-0.632.862.812.752.712.91-2.14%4.00%1.78%78.42K
2016-05-11AMC-0.632.552.922.862.553-2.05%-10.84%-12.67%529.81K
2016-03-14AMC-0.5310.3210.7510.510.1111.13-2.33%-1.71%-4.00%342.14K
2015-11-12AMC-0.3822.8423.7923.6322.0623.36-0.67%▲-3.34%-3.99%168.17K

Login | Register
Friday Nov 16, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades